Literature DB >> 10480474

Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.

W B White1, G A Mansoor, T G Pickering, D G Vidt, H G Hutchinson, R B Johnson, R Noveck.   

Abstract

The time of administration of once-daily antihypertensive agents may have a significant impact on blood pressure control during awake and sleep periods. Using 24-h ambulatory monitoring, we compared the effects of morning and evening dosing of the long-acting dihydropyridine calcium channel blocker, nisoldipine extended-release (ER), on circadian blood pressure (BP) and heart rate in patients with mild-to-moderate hypertension. After completing a 3-week placebo run-in period, 85 patients were randomized to morning versus evening nisoldipine ER treatment at a fixed 20-mg dose. Patients were treated for 4 weeks, followed by crossover to the alternate dosing regimen for 4 additional weeks. Twenty-four-hour ambulatory monitoring was performed at baseline and at 4 and 8 weeks after randomization. Awake and sleep times were determined by electronic activity recorders (Actigraphy). Similar least-squares (+/-SE) mean changes from baseline in 24-h BP (systolic BP/diastolic BP: -11.9/-7.4 +/- 0.6/0.5 v -11.6/-6.5 +/- 0.6/0.5 mm Hg) and heart rate (1.0/1.7 +/- 0.4/0.4 beats/min) occurred with morning and evening administration, respectively. A significantly greater effect on awake diastolic BP (systolic BP/diastolic BP: -12.6/-8.1 +/- 0.7/0.4 v -11.3/-6.4 +/- 0.7/0.4 mm Hg; P = .16/.01) was observed with morning dosing compared with evening dosing. In addition, small increases in sleep and early morning heart rate were seen with evening compared with morning administration of nisoldipine (sleep, 3.1 +/- 0.4 v 0.4 +/- 0.4 beats/min; P < .001; early morning, 3.5 +/- 0.7 v 0.5 +/- 0.7 beats/min; P = .002). These differential effects on awake BP and sleep heart rate were also observed in patients who had normal (dippers) and elevated (nondippers) BP values during sleep. Appropriate evaluation of the efficacy and safety of long-acting antihypertensive agents is essential when evening administration is being considered. In the present study, the timing of nisoldipine ER administration had no effect on mean changes in BP and heart rate over a 24-h period. However, nisoldipine ER had some differential effects during sleep and awake periods with morning relative to evening dosing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480474     DOI: 10.1016/s0895-7061(99)00044-8

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

1.  Appropriateness of timing of drug administration in electronic prescriptions.

Authors:  Arwa Hassan; Walter E Haefeli
Journal:  Pharm World Sci       Date:  2010-01-10

Review 2.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

Review 3.  Circadian rhythm connections to oxidative stress: implications for human health.

Authors:  Melissa Wilking; Mary Ndiaye; Hasan Mukhtar; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2013-04-24       Impact factor: 8.401

4.  Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.

Authors:  Atsushi Takeda; Takayuki Toda; Takuma Fujii; Noriaki Matsui
Journal:  Clin Exp Nephrol       Date:  2009-05-16       Impact factor: 2.801

Review 5.  Ambulatory blood pressure measurement in the renal patient.

Authors:  Adrian Covic; David J A Goldsmith
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

6.  ASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring.

Authors:  Thomas G Pickering; William B White
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-11       Impact factor: 3.738

Review 7.  Early morning blood pressure surge.

Authors:  Philippe Gosse; Helmut Schumacher
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

Review 8.  Evening versus morning dosing regimen drug therapy for hypertension.

Authors:  Ping Zhao; Ping Xu; Chaomin Wan; Zhengrong Wang
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

9.  Optimal timing for antihypertensive dosing: focus on valsartan.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423

Review 10.  Pharmacologic agents in the management of hypertension--nisoldipine coat-core.

Authors:  William B White
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-04       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.